Home › Therapeutic areas › Oncology › Hodgkin Lymphoma
Hodgkin Lymphoma (6 companies)
Companies with an active program in Hodgkin Lymphoma.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ADCT | ADC Therapeutics | Oncology | 1 | Approved | 5 |
| ARVN | Arvinas | NeurologyOncology Rare | 1 | Approved | 15 |
| CRBU | Caribou Biosciences | Oncology | 1 | Phase 3 | 4 |
| IBRX | ImmunityBio | Infectious DiseaseOncology | 1 | NDA Submitted | 16 |
| MRKR | Marker Therapeutics | Oncology | 1 | Phase 1 | 4 |
| SANA | Sana Biotechnology | MetabolicOncology | 1 | Phase 1 | 5 |
No companies match.